Baseline characteristics and ocular presentation of 28 patients who presented with suspicion of dupilumab-associated ocular surface disease
| Characteristic | Data |
| Age at consultation, years | |
| Mean±SD (range) | 45.6±14.8 (17–72) |
| Female sex | 13 (46%) |
| Bilateral eye involvement | 26 (93%) |
| Ocular history | |
| None | 6 (21%) |
| Blepharitis | 17 (61%) |
| Conjunctivitis | 3 (11%) |
| Ocular herpes simplex virus | 3 (11%) |
| Dry eye syndrome | 1 (4%) |
| Rosacea or meibomian gland dysfunction | 7 (25%) |
| Time to onset of ocular symptoms | |
| Median(first quartile, third quartile), months | 4(1, 7) |
| Time to onset ≥4 months | 17 (61%) |
| Clinical ocular signs | |
| Median (first quartile, third quartile) | 1(1, 3) |
| Blepharitis | 10 (36%) |
| Conjunctivitis | 19 (68%) |
| Dry eye syndrome | 6 (21%) |
| Limbal nodules | 7 (25%) |
| Peripheral corneal infiltrates | 7 (25%) |
| Central corneal infiltrates | 2 (7%) |
| Episcleritis | 1 (4%) |
Data are presented as frequencies (percentages) unless otherwise specified.